Belmont JW - Search Results

1

Effects of leukemia inhibitory factor (LIF) on gene transfer efficiency into murine hematolymphoid progenitors.

Fletcher FA, Moore KA, Williams DE, Anderson D, Maliszewski C, Belmont JW. Fletcher FA, et al. Among authors: belmont jw. Adv Exp Med Biol. 1991;292:131-8. doi: 10.1007/978-1-4684-5943-2_15. Adv Exp Med Biol. 1991. PMID: 1950765

2

Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals.

Etkin M, Filaccio M, Ellerson D, Suh SP, Claxton D, Gaozza E, Brenner M, Moen R, Belmont J, Moore KA, et al. Etkin M, et al. Hum Gene Ther. 1992 Apr;3(2):137-45. doi: 10.1089/hum.1992.3.2-137. Hum Gene Ther. 1992. PMID: 1391033

3

Stromal support enhances cell-free retroviral vector transduction of human bone marrow long-term culture-initiating cells.

Moore KA, Deisseroth AB, Reading CL, Williams DE, Belmont JW. Moore KA, et al. Among authors: belmont jw. Blood. 1992 Mar 15;79(6):1393-9. Blood. 1992. PMID: 1547339 Free article.

4

Leukemia inhibitory factor improves survival of retroviral vector-infected hematopoietic stem cells in vitro, allowing efficient long-term expression of vector-encoded human adenosine deaminase in vivo.

Fletcher FA, Moore KA, Ashkenazi M, De Vries P, Overbeek PA, Williams DE, Belmont JW. Fletcher FA, et al. Among authors: belmont jw. J Exp Med. 1991 Oct 1;174(4):837-45. doi: 10.1084/jem.174.4.837. J Exp Med. 1991. PMID: 1655947 Free PMC article.

5

Gene transfer of adenosine deaminase into primitive human hematopoietic progenitor cells.

Cournoyer D, Scarpa M, Mitani K, Moore KA, Markowitz D, Bank A, Belmont JW, Caskey CT. Cournoyer D, et al. Among authors: belmont jw. Hum Gene Ther. 1991 Fall;2(3):203-13. doi: 10.1089/hum.1991.2.3-203. Hum Gene Ther. 1991. PMID: 1751590

6

Evaluation of lymphoid-specific enhancer addition or substitution in a basic retrovirus vector.

Moore KA, Scarpa M, Kooyer S, Utter A, Caskey CT, Belmont JW. Moore KA, et al. Among authors: belmont jw. Hum Gene Ther. 1991 Winter;2(4):307-15. doi: 10.1089/hum.1991.2.4-307. Hum Gene Ther. 1991. PMID: 1838933

7

Stimulation of retroviral vector infection of murine hematopoietic progenitors.

Fletcher FA, Belmont JW. Fletcher FA, et al. Among authors: belmont jw. Int J Cell Cloning. 1991 Sep;9(5):491-502. doi: 10.1002/stem.1991.5530090506. Int J Cell Cloning. 1991. PMID: 1955737 Free article.

8

Gene therapy: a new approach for the treatment of genetic disorders.

Cournoyer D, Scarpa M, Jones SN, Moore KA, Belmont JW, Caskey CT. Cournoyer D, et al. Among authors: belmont jw. Clin Pharmacol Ther. 1990 Jan;47(1):1-11. doi: 10.1038/clpt.1990.1. Clin Pharmacol Ther. 1990. PMID: 1967233 Review. No abstract available.

9

Characterization of recombinant helper retroviruses from Moloney-based vectors in ecotropic and amphotropic packaging cell lines.

Scarpa M, Cournoyer D, Muzny DM, Moore KA, Belmont JW, Caskey CT. Scarpa M, et al. Among authors: belmont jw. Virology. 1991 Feb;180(2):849-52. doi: 10.1016/0042-6822(91)90105-k. Virology. 1991. PMID: 1989392

10

Murine leukemia inhibitory factor enhances retroviral-vector infection efficiency of hematopoietic progenitors.

Fletcher FA, Williams DE, Maliszewski C, Anderson D, Rives M, Belmont JW. Fletcher FA, et al. Among authors: belmont jw. Blood. 1990 Sep 15;76(6):1098-103. Blood. 1990. PMID: 2169319 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters